Table 1. Patient characteristics.
| Characteristics | Patients with perioperative ischemia (n=46) | Matched pairs without perioperative ischemia (n=46) |
|---|---|---|
| General | ||
| Age, median (range) | 62 (25-79) | 63 (36-79) |
| Female, (n) | 39.1% (18) | 39.1% (18) |
| KPS, median (range) | 80% (20-100) | 90% (40-100) |
| Surgery | ||
| GTR or STR, (n) | 84.8% (39) | 82.6% (38) |
| Partial resection, (n) | 15.2% (7) | 15.2% (7) |
| Unknown | 0% (0) | 2.2% (1) |
| Histology | ||
| Glioblastoma, (n) | 100% (46) | 100% (46) |
| MGMT-Promoter | ||
| Methylated | 45.7% (21) | 41.3% (19) |
| Not methylated | 45.7% (21) | 47.8% (22) |
| Unknown | 8.7% (4) | 10.9% (5) |
| Days to treatment, median (range) | 28 (12-66) | 30 (13-345) |
| Adjuvant treatment | ||
| Radiochemotherapy, (n) | 71.7% (33) | 71.7% (33) |
| Radiotherapy, (n) | 10.9% (5) | 10.9 % (5) |
| Temozolomide, (n) | 4.3% (2) | 4.3% (2) |
| Unknown, (n) | 10.9 % (5) | 10.9% (5) |
| No therapy, (n) | 2.2% (1) | 2.2% (1) |